Physician profile
Kristina Riser
NPI 1083216071
$2,808.88
in general payments reported to CMS, 2019-2025
18 companies · $508 in 2025
The $508 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $11.16 · 2022: $661 · 2023: $754 · 2024: $874 · 2025: $508.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,136.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $465.34 | 2022-2025 | Abilify Asimtufii, Abilify Maintena, Rexulti |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $432.57 | 2022-2025 | Caplyta |
| Abbvie INC. | $336.35 | 2022-2025 | |
| Vanda Pharmaceuticals INC. | $313.25 | 2022-2025 | Fanapt, Hetlioz |
| Alkermes, INC. | $204.74 | 2022-2025 | Aristada, Lybalvi, Aristada Initio |
| Axsome Therapeutics, INC. | $195.71 | 2024-2025 | Auvelity |
| Supernus Pharmaceuticals, INC. | $187.31 | 2022-2025 | Qelbree |
| Lundbeck LLC | $157.84 | 2022-2025 | Abilify Maintena, Rexulti |
| Teva Pharmaceuticals USA, INC. | $148.35 | 2022-2024 | Uzedy, Austedo, Austedo Xr |
| Janssen Pharmaceuticals, INC | $103.31 | 2021-2024 | Invega Sustenna, Invega Trinza, Spravato |
| Ironshore Pharmaceuticals INC. | $53.48 | 2022-2024 | |
| Neurocrine Biosciences, INC. | $46.06 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $44.85 | 2025 | Cobenfy |
| Indivior INC. | $40.67 | 2023 | Perseris |
| Takeda Pharmaceuticals U.S.A., INC. | $24.37 | 2023 | Trintellix |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $19.24 | 2022 | |
| Collegium Pharmaceutical, INC. | $18.51 | 2025 | Jornay Pm |
| Sunovion Pharmaceuticals INC. | $16.93 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristina Riser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.